EsoBiotec
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $3.9M
Investors
- 4
About EsoBiotec
Based in Belgium, and founded in 2020, EsoBiotec operates as a biotechnology company that offers gene therapy solutions for cancer treatment. The company was founded by its CEO, Jean-Pierre Latere. EsoBiotec offers biotech research solutions, including the development and commercialization of therapeutic products such as cell therapy and cancer therapies for the medical sector. The company uses in vivo-engineered CAR-T cells and genetic material to create therapies that target specific types of cancer cells. The firm provides off-the-shelf therapeutics for the treatment of cancer.
Who invested in EsoBiotec
4 investors across 2 rounds
See all investors in EsoBiotec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EsoBiotec
Who invested in EsoBiotec?
EsoBiotec has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EsoBiotec raised?
EsoBiotec has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EsoBiotec last raise money?
EsoBiotec's most recent round on record is a Series A, in Dec 2023.
What does EsoBiotec do?
Based in Belgium, and founded in 2020, EsoBiotec operates as a biotechnology company that offers gene therapy solutions for cancer treatment.
Where is EsoBiotec headquartered?
EsoBiotec is headquartered in Belgium.
Which VCs invest in companies like EsoBiotec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at EsoBiotec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EsoBiotec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.